On March 6, 2023 Cytokinetics, Incorporated (Nasdaq: CYTK) reported that the company is scheduled to participate in the following investor conferences (Press release, Cytokinetics, MAR 6, 2023, View Source [SID1234628210])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Oppenheimer 33rd Annual Healthcare Conference: Robert I. Blum, President and Chief Executive Officer, will present virtually on Monday, March 13, 2023 at 10:00 AM Eastern Time.
Barclays Global Healthcare Conference: Robert I. Blum, President and Chief Executive Officer, will participate in a Fireside Chat on Wednesday, March 15, 2023 at 3:35 PM Eastern Time at the Loews Miami South Beach Hotel in Miami Beach, FL.
Jefferies 2023 Biotech on the Bay Summit: Management will participate in one-on-one meetings on Thursday, March 16, 2023 at the 1 Hotel South Beach in Miami Beach, FL.
Interested parties may access the live webcast of these presentations by visiting the Investors & Media section of the Cytokinetics website at www.cytokinetics.com. The webcast replay will be archived on the Presentations page within the Investors & Media section of Cytokinetics’ website for 90 days following the conclusion of the event.